SuperworthSolid Biosciences shares outstanding SLDB
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 143.7M
- On a year earlier
- +52.6%
- more shares
Solid Biosciences had 143.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 52.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 94.7M | +122% |
| FY2024 | 42.7M | +111% |
| FY2023 | 20.2M | +77% |
| FY2022 | 11.5M | +52% |
| FY2021 | 7.5M | +79% |
| FY2020 | 4.2M | +32% |
| FY2019 | 3.2M | +38% |
| FY2018 | 2.3M | +101% |
| FY2017 | 1.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 143.7M | +53% | |
| Q1 FY26 | 109.8M | +66% | |
| Q4 FY25 | 94.7M | +122% | |
| Q3 FY25 | 94.4M | +128% | |
| Q2 FY25 | 94.1M | +130% | |
| Q1 FY25 | 66.3M | +74% | |
| Q4 FY24 | 42.7M | +111% | |
| Q3 FY24 | 41.4M | +107% | |
| Q2 FY24 | 40.9M | +108% | |
| Q1 FY24 | 38.2M | +95% | |
| Q4 FY23 | 20.2M | +77% | |
| Q3 FY23 | 20.1M | +166% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Solid Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.